Log In
Register

Packaging
Ingredients
Brands & Products
Leaders
Retail
Consumers & Markets
Multimedia
Events

Topics

Packaging
Ingredients
Brands & Products
Leaders
Retail
Consumers & Markets
Multimedia
Events
Polls

Magazine

Advisory Board
Past Issues
Product Roundup
Subscribe

User Tools

Log In
Register
Contact Us
Editorial Submissions
Advertise
Privacy Policy
Legal Terms

Oral Care

Symrise USA

Aug 17th, 2019

Duellberg Konzentra GmbH & Co. KG

Read the latest issue

Read Current Issue Subscribe Now

Follow Us

Interesting Stories

For the first time in more than two decades, a new, innovative UV filter is on the brink of FDA approval in the United States, and it’s set to transform everything we know about sun protection.

A Sunscreen Revolution Is Coming to the US

Unilever Announces Sale of Kate Somerville to Rare Beauty

Unica's Triple-Mix Bottle: Effortless Dispensing for Multi-Formula Products

Sponsored

Unica's Triple-Mix Bottle: Effortless Dispensing for Multi-Formula Products

Fenty is valued somewhere between $1 billion to $2 billion.

LVMH Explores Sale of 50% Stake in Rihanna's Fenty Beauty, Valued Between $1-2 Billion

Based on current projections, the combined company would generate 2025 annual net revenues of approximately $32 billion and approximately $7 billion of adjusted EBITDA

Kimberly-Clark to Acquire Kenvue for Combined Revenue of $32 Billion

Push back the limits of cell aging

Sponsored

Push back the limits of cell aging

In a world where beauty is no longer just skin deep, dsm-firmenich Beauty & Care is leading a transformative movement—one that unites science, sustainability, and emotional connection to shape the future of the industry.

dsm-firmenich: Elevating Beauty through Purpose and Scientific Impact

Beyond beauty, Kering and L’Oréal are joining forces to explore business opportunities at the intersection of luxury, wellness and longevity.

L'Oreal's $4.6B Kering Deal Includes Creed Acquisition, Licenses for Gucci and More

© 2025 Allured Business Media. All rights reserved.

Contact Us
Editorial Submissions
Advertise
Privacy Policy
Legal Terms
Site Map